Advanced Practice Midwife in West Seneca, NY Accepting Medicare

5 Advanced Practice Midwife nurses found. Showing 1 - 5

Mrs. Kelly Vargo, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3050 Orchard Park Road, West Seneca, NY 14224 Phone: 716-675-5222    Fax: 716-675-9329

Mrs. Kimberly Cherie Mecca, MIDWIFE Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3050 Orchard Park Rd, West Seneca, NY 14224 Phone: 716-675-5222    Fax: 716-675-9329

Ann R Powell, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 130 Empire Dr, Empire Drive Health Center, West Seneca, NY 14224 Phone: 716-668-6170    Fax: 716-656-4074

Mrs. Jeanette Baxter, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3050 Orchard Park Road, West Seneca, NY 14224 Phone: 716-675-5222    Fax: 716-675-9329

Mrs. Katharyn Sexton, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3050 Orchard Park Road, West Seneca, NY 14224 Phone: 716-675-5222    Fax: 716-675-9329

News Archive

FDA issues warning on psoriasis drug Raptiva (efalizumab)

The U.S. Food and Drug Administration has issued a public health advisory concerning three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, in patients using the psoriasis drug Raptiva (efalizumab).

National HCGNE announces $1.38M in awards to Claire M. Fagin Fellows, Patricia G. Archbold Scholars

The National Hartford Centers of Gerontological Nursing Excellence (HCGNE) today announced $1.38 million in awards to the latest cohort of Claire M. Fagin Fellows and Patricia G. Archbold Scholars studying gerontological nursing in academic settings across the U.S.

Gum disease linked to stroke

A pair of new studies has revealed that gum diseases could be associated with a heightened risk of strokes and atherosclerosis of hardening of the arterial walls. The results of this new research are to be presented at the American Stroke Association's International Stroke Conference 2020 between 19th and 21st of February 2020 in Los Angeles.

Plexxikon presents promising preclinical data from PLX3397 in vivo cancer studies

Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.

Read more Medical News

› Verified 6 days ago